sodium 3-[[1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxo-pentan-2-yl]carba moyl]oxirane-2-carboxylate

Modify Date: 2024-01-28 17:34:42

sodium 3-[[1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxo-pentan-2-yl]carba moyl]oxirane-2-carboxylate structure	Common Name	sodium 3-[[1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxo-pentan-2-yl]carba moyl]oxirane-2-carboxylate
	CAS Number	84456-39-3	Molecular Weight	425.45400
	Density	N/A	Boiling Point	663.2ºC at 760 mmHg
	Molecular Formula	C₂₁H₂₈N₃NaO₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Name	sodium,3-[[1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate

Boiling Point	663.2ºC at 760 mmHg
Molecular Formula	C₂₁H₂₈N₃NaO₅
Molecular Weight	425.45400
Exact Mass	425.19300
PSA	108.80000
LogP	1.30230

CHEMICAL IDENTIFICATION

RTECS NUMBER :: RR0404507

CHEMICAL NAME :: Oxiranecarboxylic acid, 3-(((3-methyl-1-((4-(phenylmethyl)-1-piperazinyl)carb onyl)butyl) amino)carbonyl)-, monosodium salt

CAS REGISTRY NUMBER :: 84456-39-3

LAST UPDATED :: 199609

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C21-H28-N3-O5.Na

MOLECULAR WEIGHT :: 425.51

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD - Lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >1125 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4507297